Integrating Modelling of Metabolism and Signalling towards an Application in Liver Cancer (ERASysAPP - IMOMESIC)
Research Project , 2014 – 2018

Uncontrolled proliferation in cancer results from synergistic adaptations in metabolism and signalling. However, due to the complexity, coupling mechanisms between metabolism and signalling are difficult to assess and it remains to be clarified how they give rise to cooperative enhancement. As a proof of concept, we focus on liver cancer, and propose a combined experimental and modelling approach that exploits both, comprehensive genome-scale models to identify global, cancer-specific alterations as well as a more detailed integrative model that links glycolysis and signalling. We will develop standard operating procedures for combined quantitative studies of metabolism and signal transduction in healthy and cancer cells, elucidate alterations in signalling and gene expression causing glycolytic adaptations and predict cancer-cell selective drug combinations using mathematical modelling of healthy and cancer cells. The proposed approach will act as a model study for systems biology approaches to integrate metabolism and signalling in oncology and will open new avenues for the treatment of liver cancer.


Jens B Nielsen (contact)

Full Professor at Chalmers, Biology and Biological Engineering

Adil Mardinoglu

Forskarassistent at Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology

Avlant Nilsson

Post doc at Chalmers, Biology and Biological Engineering, Systems and Synthetic Biology


Charité University Medicine Berlin

Berlin, Germany

Free University of Amsterdam

Amsterdam, Netherlands

German Cancer Research Center (DKFZ)

Heidelberg, Germany

Griffin Discoveries

Amsterdam, Netherlands

University of Freiburg

Freiburg, Germany


Swedish Research Council (VR)

Funding Chalmers participation during 2014–2018

Related Areas of Advance and Infrastructure

Sustainable development

Driving Forces


More information

Latest update